Assessing Drug Prescribing Patterns in Cancer Care
Recent observations suggest cancer patients might be receiving unwarranted high doses and lengthy treatments of costly medications.
Entertainment news, movies, and celebrities
Recent observations suggest cancer patients might be receiving unwarranted high doses and lengthy treatments of costly medications.
Long-term HIV survivors worry that a cure might jeopardize their essential support services, highlighting the need for thoughtful policy considerations.
Regeneron and Ultragenyx receive FDA approvals for significant therapies aimed at rare diseases, offering new hope for affected patients.
The recent success of Merck and Moderna's personalized mRNA cancer therapy marks a pivotal moment in cancer treatment advancements.
Healthcare providers are increasingly adopting AI chatbots to navigate complex patient records, improving diagnosis and patient care.
Erica Schwartz, the new CDC director, emphasizes transparency and empowerment in her inaugural address, ready to challenge administration leaders as needed.
Regeneron's new drug, Pasatru, is approved to treat fibrodysplasia ossificans progressiva, aiming to significantly improve patient outcomes.
The ACS has canceled its Wine and Spirits Industry Gala, reconsidering fundraising methods amid concerns over conflicts with its mission.
A Harvard team has kept brain organoids alive for over five years, revealing developmental insights that advance our understanding of human brains.
Elisabeth Marnik transformed her life by embracing vaccinations, using her own journey to advocate for science communication and understanding diverse perspectives.
The potential removal of racism from public health competencies raises fears of undermining efforts to address systemic inequities and health disparities.
Experts weigh in on the controversial gene editing trial by Huidagene, offering mixed reviews of the science behind it after a tragic incident.
Bristol Myers Squibb's approval of Zenbexus for multiple myeloma highlights its new drug class, while a lawsuit over delayed approvals remains unresolved.
Today, vehicles monitor driver behavior, feeding data to insurers who adjust premiums based on the findings.
Skylark Bio has initiated a clinical trial aimed at treating hearing loss in children with GJB2 mutations, following advancements in gene therapy.
Abortion care is evolving, with patients increasingly turning to digital solutions for reliable information and medical guidance.
MoonLake Immunotherapeutics faces scrutiny for vague disclosures on its autoimmune drug candidate, raising questions about its trial results’ credibility.
Medicare's “Bridge” program aims to lower costs for GLP-1 medications, yet its complexity may hinder patient access to affordable treatments.
The recent Senate hearings on Covid-19's origins spotlight political distractions, while China's suppression of information remains a pivotal issue.
The NIH's proposed changes to funding eligibility may limit opportunities for international researchers on visas in the U.S. biomedical sector.